Download MendeleyOxaliplatin inhibits angiogenin proliferative and cell migration effects in prostate cancer cells.
Marzo, T., Ferraro, G., Cucci, L.M., Pratesi, A., Hansson, O., Satriano, C., Merlino, A., La Mendola, D.(2022) J Inorg Biochem 226: 111657-111657
- PubMed: 34784565
- DOI: https://doi.org/10.1016/j.jinorgbio.2021.111657
- Primary Citation of Related Structures:
7NPM - PubMed Abstract:
Angiogenin (Ang) is a potent angiogenic protein that is overexpressed in many types of cancer at concentration values correlated to the tumor aggressiveness. Here, by means of an integrated multi-technique approach based on crystallographic, spectrometric and spectroscopic analyses, we demonstrate that the anti-cancer drug oxaliplatin efficiently binds angiogenin. Microscopy cellular studies, carried out on the prostate cancer cell (PC-3) line , show that oxaliplatin inhibits the angiogenin prompting effect on cell proliferation and migration, which are typical features of angiogenesis process. Overall, our findings point to angiogenin as a possible target of oxaliplatin, thus suggesting a potential novel mechanism for the antineoplastic activity of this platinum drug and opening the avenue to novel approaches in the combined anti-cancer anti-angiogenic therapy.
Organizational Affiliation:
Department of Pharmacy, University of Pisa, Via Bonanno Pisano 6, 56126 Pisa, Italy.
